No Photo Available

Last Update

2016-07-09T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Michael Cicio?

Dr. Michael J. Cicio

Vice President, Commercial Recombinant Manufacturing

Baxalta Incorporated

Direct Phone: (617) ***-****       

Email: m***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Baxalta Incorporated

1200 Lakeside Drive

Deerfield, Illinois 60015

United States

Company Description

Baxalta Incorporated (NYSE: BXLT) is a global biopharmaceutical leader developing, manufacturing and commercializing therapies for orphan diseases and underserved conditions in hematology, immunology and oncology. Driven by passion to make a meaningful im ... more

Find other employees at this company (6,801)

Background Information

Employment History

Vice President Operations

Plant Manager Portsmouth

Vice President Operations, Pharma and Biotech US and Asia

Lonza Group Ltd

Director, BioPharma Operations Network Drug Substance

Wyeth

Affiliations

National Visiting Committee Member
Northeast Biomanufacturing Center and Collaborative

Committee Member
VP Operations Pharma & Biotech , US/Asia

National Visiting Committee Member
NBC2

Web References (21 Total References)


Northeast Biomanufacturing Center & Collaborative – National Visiting Committee Members

biomanufacturing.org [cached]

Michael Cicio

Lonza Biologics, Inc.
Expand Bio
...
Michael Cicio


Michael ...

www.biomanufacturing.org [cached]

Michael Cicio Committee Member VP Operations Pharma & Biotech, US/Asia


Since 2010, Lonza has been ...

www.biopharma-reporter.com [cached]

Since 2010, Lonza has been working with GSK on designs for a £370m ($574m) biomanufacturing facility in Ulverston, UK . BioPharma-Reporter asked Michael Cicio - VP Operations at Lonza Biologics what he considers are the three most important design issues to consider when constructing a new plant.

"Compliance in room classification design, validation and operation," is the first he said, followed by "simplicity of design in order to allow for quicker validation.
...
Both Estapé and Cicio also told us new biopharmaceutical technologies - better bioreactors, more efficient processing systems - and the growing acceptance of disposable systems are also impacting facility design, and driving the need for greater flexibility.
...
However, Cicio continued: "If a structure was to be demolished it may be due to what the facility made before and what the plans are for the new facility.


Northeast Regional Biomanufacturing Collaborative

www.biomanufacturing.org [cached]

Michael Cicio VP Operations and Site Manager Lonza Biologics, Inc. 101 International Drive Portsmouth, NH 03801 michael.cicio@lonza.com 603-610-4553


Michael Cicio's ...

www.dubuque.com [cached]

Michael Cicio's picture

...
Michael Cicio Committee Member VP Operations Pharma & Biotech, US/Asia

Similar Profiles

Other People with this Name

Other people with the name Cicio

Leonard Cicio
Douglas Elliman LLC

Mark Cicio
Creative Environment Solutions Corp.

Gina Cicio
Geisinger Medical Center

Peter Cicio
Marjam Supply Company

Frank Cicio
iQ4 Corporations

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory